
Molecular Medicine, Journal Year: 2024, Volume and Issue: 30(1)
Published: Sept. 28, 2024
Language: Английский
Molecular Medicine, Journal Year: 2024, Volume and Issue: 30(1)
Published: Sept. 28, 2024
Language: Английский
Genes & Diseases, Journal Year: 2025, Volume and Issue: unknown, P. 101567 - 101567
Published: Feb. 1, 2025
Language: Английский
Citations
0International Journal of Molecular Medicine, Journal Year: 2024, Volume and Issue: 55(1)
Published: Oct. 23, 2024
A dynamic balance exists between osteogenesis and osteoclastogenesis in bone tissue, which can lead to several diseases, such as osteoporosis, osteoarthritis, necrosis defects, cases of insufficient or excessive osteoclastogenesis. NEL‑like molecule‑1 (NELL‑1) was first discovered 1999 an osteogenic factor that prevent treat diseases by increasing levels. To date, research has identified multiple signaling pathways involved improving Furthermore, apply NELL‑1 clinical practice, researchers have optimized its effect combining it with other molecules, changing molecular structure performing tissue engineering. Currently, on is gaining attention. In the near future, will definitely be applied practice eliminate diseases. Thus, present study provides a comprehensive review enhancing levels from perspectives mechanism, interactions molecules/cells, molecular‑level changes, applications engineering expression tumors, providing solid theoretical basis for application.
Language: Английский
Citations
3Molecular Medicine, Journal Year: 2024, Volume and Issue: 30(1)
Published: Sept. 28, 2024
Language: Английский
Citations
1